Annovis Bio Files New Patent for Novel Solid Forms of Buntanetap With U.S. Patent Office; Builds on Provisional Patent From June 2023
Portfolio Pulse from Benzinga Newsdesk
Annovis Bio has filed a new patent for novel solid forms of Buntanetap with the U.S. Patent Office, building on a provisional patent from June 2023.
June 26, 2024 | 12:01 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Annovis Bio has filed a new patent for novel solid forms of Buntanetap, which could enhance its intellectual property portfolio and potentially lead to new product developments.
The filing of a new patent can strengthen Annovis Bio's intellectual property portfolio, potentially leading to new product developments and enhancing the company's market position. This is likely to have a positive short-term impact on the stock price.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100